Mechanical Dilatation of the Cervix at Elective Caesarean Section to Reduce Post-Operative Blood Loss
Mechanical Dilatation vs Non-Dilatation of the Cervix at Elective Caesarean Section to Reduce Post-Operative Blood Loss
1 other identifier
interventional
774
1 country
1
Brief Summary
obstetric hemorrhage remains one of the major causes of maternal death in both developed and developing countries. Because of its importance as a leading cause of maternal mortality and morbidity, and because of evidence of substandard care in the majority of fatal cases, obstetric hemorrhage must be considered as a priority topic for national guideline development. Some obstetricians believe that the cervix of women at non-labor cesarean section is undilated and might cause obstruction of blood or lochia drainage, leading to postpartum hemorrhage and endometritis from the collection of lochia or debris. Dilatation of the cervix helps with the drainage of blood during postpartum, reducing intrauterine infection or the risk of postpartum hemorrhage. To avoid this problem, some obstetricians routinely dilate the cervix from above during an elective/ non-labor cesarean section using finger, sponge forceps or other instruments
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 10, 2018
CompletedFirst Submitted
Initial submission to the registry
February 19, 2018
CompletedFirst Posted
Study publicly available on registry
February 23, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 20, 2018
CompletedJuly 6, 2018
July 1, 2018
4 months
February 19, 2018
July 3, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Vaginal bleeding during the 1st 24 hours postoperative.
The amount of vaginal bleeding will be calculated according to number of soaked pads used after the cesarean section for the 1st 24 hours. Where each soaked pad = 50 cc
the 1st 24 hours postoperative.
Secondary Outcomes (2)
intraoperative blood loss
during the time of the operation
Total blood loss
operation time plus the 1st 24 hours after operation
Study Arms (2)
Group I (dilation group)
EXPERIMENTALthe surgeon will perform the cervical dilatation by inserting the double-gloved index finger into the cervical canal of the patients after the extraction of placenta and membranes. The outer glove will be removed after this procedure. - If failed we will use artery forceps to dilate cervix
Group II (non dilatation group)
NO INTERVENTIONthe surgeon will perform cesarian section without attempting cervical dilatation
Interventions
the surgeon will perform the cervical dilatation by inserting the double-gloved index finger into the cervical canal of the patients after the extraction of placenta and membranes. The outer glove will be removed after this procedure. \- If failed the surgeon will use artery forceps to dilate cervix
Eligibility Criteria
You may qualify if:
- pregnant women with a single term fetus \>37 weeks of gestational age, with American Society of Anesthesiology (ASA) physical status I or II undergoing Elective Cs (primary or repeated CS).
- Age group 20 - 35 years old
You may not qualify if:
- Chorioamnionitis.
- Placenta previa.
- Multiple gestations.
- Preeclampsia.
- Macrosomia.
- Hydramnios.
- Uterine leiomyomata.
- Anemia.
- Previous cervical surgery.
- Previous post-partum hemorrhage.
- Bleeding tendency.
- Hypertension.
- Diabetes mellitus.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Faculty of Medicine Cairo University
Cairo, 11231, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
mohamed sharkawy, assis.prof.
Cairo University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The included patients will be randomized using sealed opaque envelope method into two groups
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer in obstetrics and gynecology
Study Record Dates
First Submitted
February 19, 2018
First Posted
February 23, 2018
Study Start
February 10, 2018
Primary Completion
June 15, 2018
Study Completion
June 20, 2018
Last Updated
July 6, 2018
Record last verified: 2018-07